SCHEMBL366680

SCHEMBL366680

CCC(CC)(CO)c1ncc[nH]1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.39
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
FDPS P14324 1/20 0.32
TXN P10599 1/20 0.32
TXNRD1 Q16881 1/20 0.32
HTR1A P08908 1/20 0.31
TAAR1 Q96RJ0 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
F2RL1 P55085 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23555331 0.81 ALDH1A1 (0.35) CYP19A1ALDH1A1SMN1; SMN2TXNTXNRD1
SCHEMBL9459967 0.76 CYP19A1 (0.41) CYP19A1ALDH1A1SMN1; SMN2FDPSTXN
SCHEMBL29749649 0.75 ALDH1A1 (0.41) CYP19A1ALDH1A1SMN1; SMN2FDPSTXN
SCHEMBL13493243 0.74 ALDH1A1 (0.39) CYP19A1ALDH1A1SMN1; SMN2FDPSTXN
SCHEMBL3707615 0.74 ALDH1A1 (0.39) CYP19A1ALDH1A1SMN1; SMN2FDPSTXN
SCHEMBL5057625 0.73 CYP19A1 (0.46) CYP19A1ALDH1A1SMN1; SMN2FDPSTXN
SCHEMBL27951250 0.72 ALDH1A1 (0.38) CYP19A1ALDH1A1SMN1; SMN2FDPSTXN
SCHEMBL11306595 0.72 CYP19A1 (0.39) CYP19A1ALDH1A1SMN1; SMN2TXNTXNRD1
SCHEMBL17104430 0.69 CYP19A1 (0.39) CYP19A1ALDH1A1SMN1; SMN2TXNTXNRD1
SCHEMBL5500827 0.69 CYP19A1 (0.39) CYP19A1ALDH1A1SMN1; SMN2FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed